The present invention is directed to several newly discovered ecteinascidin (Et) species, designated herein as Et 731, Et 745B, Et 815, Et 808, Et 596

Asymmetric Total Syntheses of Ecteinascidin 597 and Ecteinascidin 583.

Plitidepsin en los Carcinomas Indiferenciados .